VIROLOGY RESEARCH SERVICES
  • About
    • About Us
    • Our Facilities
    • Accreditations
    • News
  • Services & Products
    • Industrial Testing
      • ISO21702
      • ISO18184
      • Suspension test
      • DIN EN 14476
      • ASTM E1052
      • ASTM E1053
      • M40-A2
      • Cytotoxicity Assay
      • ISO 22196
      • ISO 20743
    • Antiviral Assays
      • IC50
      • Antiviral Drug Screening
      • Air-liquid Interface Cell Culture
      • Organoids
    • Detection & Quantification
      • TCID50 Assays
      • Plaque & Immunofocus Assays
      • qPCR Services
    • Other Services
      • Neutralization Assays
      • Antibody Dependent Enhancement
      • ELISA Services
      • High Throughput Imaging
    • Virology Products
      • Detect Pro Influenza B Real-Time PCR Detection Kit
      • Detect Pro Influenza A Real-Time PCR Detection Kit
  • Viruses
  • Learn
    • Courses
    • Videos
    • Blog
  • Tools
    • TCID50 Calculator
    • MOI Calculator
    • HAI Assay Calculator
    • HA Titre Calculator
  • Contact Us
Select Page
How do you diagnose polyomavirus infection in immunocompromised patients?

How do you diagnose polyomavirus infection in immunocompromised patients?

by Virology Research Services | Feb 18, 2020 | ASK VRS

In our ASK VRS series, every month we will reply to a question asked through our website or social media. This month, Ali sent us the following question: Can I search for polyomavirus specific IgG and IgM antibodies in cancer patients’ serum or, because they are...
The making of dengue virus: the 3′ UTR

The making of dengue virus: the 3′ UTR

by Virology Research Services | Dec 19, 2019 | Virus of the Month

In the first blog of our dengue series, we described dengue’s 5′ untranslated region (UTR) – a relative short sequence (around 100 nucleotides) that includes two elements essential for genome replication: (i) the promoter for RNA synthesis, (known as stem-loop A), and...
How do you go about making a vaccine? – II Part

How do you go about making a vaccine? – II Part

by Virology Research Services | Dec 19, 2019 | Virus Methods

Preclinical testing comes at a relatively early stage in vaccine discovery, as the development of an immune response following antigen administration can only be tested in an organism. If adequate models are available, protection from (or attenuation of) viral...
Why bird flu doesn’t do well in humans

Why bird flu doesn’t do well in humans

by Virology Research Services | Dec 19, 2019 | VRS Blog

Influenza A viruses are a common concern among many animal species, including birds, horses, pigs, and humans and the effects can range from asymptomatic to severe respiratory injury leading to death. The low fidelity of the genome-replication machinery – together...
How do you go about making a vaccine? – I Part

How do you go about making a vaccine? – I Part

by Virology Research Services | Nov 29, 2019 | Virus Methods

How do you go about making a vaccine? We received this very pertinent question from a sci-fi author a few weeks ago, and thought it was worth a new short blog series! This month we cover the early R&D stages of vaccine discovery, while in the next blog, we’ll talk...

Posts pagination

< 1 … 12 13 14 … 32 >
Page 13 of 32
  • Home
  • About
  • Services
  • Viruses
  • Blog
  • Contact

Address

Virology Research Services Ltd

Building 980

Cornforth Drive

Kent Science Park

Sittingbourne

ME9 8PX

United Kingdom

Company Number: 11718460
VAT number: 314515334

Contact us

vrs@virologyresearchservices.com

Follow us

  • Follow
  • Follow

Privacy Policy

Virology Research Services © Copyright 2025